| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO
1 company
Imran Talat is a Chief Executive Officer at RANI. Recent filings cover 7 purchases and 1 sale. Those positions are worth an estimated $374K at current prices.
Our model assigns Imran Talat a middling insider score of 53/100, based on 5 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -8.0%.
Imran Talat's largest disclosed position is in RANI as Chief Executive Officer, worth about $374K. Net of sales, the recent Form 4 record there shows accumulation of 77,282 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | RANI Rani Therapeutics Holdings, Inc. | Chief Executive Officer | Buy | 35,000 | $0.72 | $25,193.00 | +8.1% | - | - | |
| Dec 27, 2024 | RANI Rani Therapeutics Holdings, Inc. | Chief Executive Officer | Sell | 8,014 | $1.41 | $11,299.74 | -1.6% | - | - | |
| Dec 9, 2024 | Chief Executive Officer | Buy | 10,296 | $1.94 | $19,974.24 | +2.1% | -23.3% | -19.7% | ||
| Dec 6, 2023 | Chief Executive Officer | Buy | 10,000 | $2.27 | $22,700.00 | +2.1% | +48.8% | -26.6% | ||
| Dec 4, 2023 | Chief Executive Officer | Buy | 5,000 | $2.57 | $12,850.00 | +1.1% | +46.6% | -22.5% | ||
| Nov 29, 2023 | Chief Executive Officer | Buy | 20,000 | $2.05 | $41,000.00 | +4.4% | +75.4% | +3.6% | ||
| Nov 7, 2023 | Chief Executive Officer | Buy | 5,000 | $2.00 | $9,975.00 | +0.6% | +86.4% | +25.3% |